TOP NEWS: GSK Gets Positive Result From Early Dostarlimab Cancer Study
LONDON (Alliance News) - GlaxoSmithKline PLC on Tuesday said data from the early-stage Garnet clinical study had promising results for the use of Dostarlimab in patients with endometrial was by by Read More